UY34535A - Nuevo uso terapéutico de antagonistas del receptor p75. - Google Patents
Nuevo uso terapéutico de antagonistas del receptor p75.Info
- Publication number
- UY34535A UY34535A UY0001034535A UY34535A UY34535A UY 34535 A UY34535 A UY 34535A UY 0001034535 A UY0001034535 A UY 0001034535A UY 34535 A UY34535 A UY 34535A UY 34535 A UY34535 A UY 34535A
- Authority
- UY
- Uruguay
- Prior art keywords
- therapeutic use
- new therapeutic
- receiver antagonists
- antagonists
- receiver
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- FWYUJENICVGSJH-UHFFFAOYSA-M sodium;2-[bis[2-[2-(2-methyl-5-nitroimidazol-1-yl)ethoxy]-2-oxoethyl]amino]acetate Chemical compound [Na+].CC1=NC=C([N+]([O-])=O)N1CCOC(=O)CN(CC([O-])=O)CC(=O)OCCN1C([N+]([O-])=O)=CN=C1C FWYUJENICVGSJH-UHFFFAOYSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4995—Pyrazines or piperazines forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención proporciona el uso de un antagonista del receptor p75 o sus sales farmacéuticamente aceptables para la preparación de un medicamento para uso en el tratamiento y/o prevención de vejiga sobreactiva.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306709.4A EP2606894A1 (en) | 2011-12-20 | 2011-12-20 | Novel therapeutic use of p75 receptor antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY34535A true UY34535A (es) | 2013-07-31 |
Family
ID=47429839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY0001034535A UY34535A (es) | 2011-12-20 | 2012-12-20 | Nuevo uso terapéutico de antagonistas del receptor p75. |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US20140296513A1 (es) |
| EP (2) | EP2606894A1 (es) |
| JP (2) | JP6275649B2 (es) |
| KR (1) | KR20140103151A (es) |
| CN (1) | CN104144688B (es) |
| AR (1) | AR089344A1 (es) |
| AU (2) | AU2012356922B2 (es) |
| BR (1) | BR112014014933A2 (es) |
| CA (1) | CA2859582A1 (es) |
| CL (1) | CL2014001619A1 (es) |
| CO (1) | CO6990740A2 (es) |
| CR (1) | CR20140298A (es) |
| DO (1) | DOP2014000137A (es) |
| EA (1) | EA028616B1 (es) |
| HK (1) | HK1198580A1 (es) |
| IL (1) | IL233189A0 (es) |
| MA (1) | MA35850B1 (es) |
| MX (1) | MX2014007673A (es) |
| PE (1) | PE20141854A1 (es) |
| PH (1) | PH12014501390A1 (es) |
| SG (1) | SG11201403390QA (es) |
| TN (1) | TN2014000269A1 (es) |
| UY (1) | UY34535A (es) |
| WO (1) | WO2013092918A1 (es) |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3236243A1 (de) | 1982-09-30 | 1984-04-05 | Merck Patent Gmbh, 6100 Darmstadt | Schwefelhaltige indolderivate |
| FR2744448B1 (fr) | 1996-02-02 | 1998-04-24 | Pf Medicament | Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments |
| KR20000052691A (ko) | 1996-10-21 | 2000-08-25 | 스트라칸 그라함 | 뉴로트로핀 길항제 조성물 |
| US6613942B1 (en) | 1997-07-01 | 2003-09-02 | Novo Nordisk A/S | Glucagon antagonists/inverse agonists |
| JP2003514508A (ja) | 1997-07-01 | 2003-04-15 | ノボ ノルディスク アクティーゼルスカブ | グルカゴン拮抗剤／逆作用剤 |
| DE19826841A1 (de) | 1998-06-16 | 1999-12-23 | Merck Patent Gmbh | Arylalkanoylpyridazine |
| GB9905010D0 (en) | 1999-03-04 | 1999-04-28 | Merck Sharp & Dohme | Therapeutic agents |
| EP1165522A1 (en) | 1999-04-06 | 2002-01-02 | Krenitsky Pharmaceuticals, Inc. | Neurotrophic thio substituted pyrimidines |
| US6468990B1 (en) | 1999-05-17 | 2002-10-22 | Queen's University At Kingston | Method of inhibiting binding of nerve growth factor to p75 NTR receptor |
| FR2803593B1 (fr) | 2000-01-06 | 2002-02-15 | Sanofi Synthelabo | Nouvelles tetrahydropyridines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| UA77526C2 (en) | 2002-06-07 | 2006-12-15 | Sanofi Aventis | Substituted derivatives of 1-piperazineacylpiperidine, a method for the preparation thereof and their use in therapy |
| FR2862967B1 (fr) | 2003-12-01 | 2006-08-04 | Sanofi Synthelabo | Derives de (4-phenylpiperazin-1-yl)acylpiperidine, leur preparation et leur application en therapeutique |
| FR2862968B1 (fr) | 2003-12-01 | 2006-08-04 | Sanofi Synthelabo | Derives de 4-[(arylmethyl)aminomethyl]piperidine, leur preparation et leur application en therapeutique |
| AR050365A1 (es) | 2004-08-02 | 2006-10-18 | Osi Pharm Inc | Compuestos inhibidores de multi- quinasa pirrolopirimidina aril- amino sustituidos. |
| AU2006291994A1 (en) * | 2005-09-15 | 2007-03-22 | Painceptor Pharma Corporation | Methods of modulating neurotrophin-mediated activity |
| US20110071180A1 (en) | 2008-03-05 | 2011-03-24 | Targacept, Inc. | Sub-type selective amides of diazabicycloalkanes |
| CN102083830B (zh) | 2008-03-24 | 2014-11-12 | 梅迪维新技术公司 | 吡啶并[3,4-b]吲哚和应用方法 |
| CN101284838B (zh) | 2008-06-06 | 2011-05-04 | 天津药物研究院 | 含噻吩并吡啶的哌嗪类衍生物、其制备方法和用途 |
| FR2932481B1 (fr) | 2008-06-13 | 2010-10-08 | Sanofi Aventis | Derives de 4-{2-°4-phenyl-3,6-dihydro-2h-pyridin-1-yl!-2- oxo-alkyl}-1-piperazin-2-one, leur preparation et leur application en therapeutique. |
| FR2932482B1 (fr) * | 2008-06-13 | 2010-10-08 | Sanofi Aventis | Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75 |
| JP2010254641A (ja) * | 2009-04-28 | 2010-11-11 | Astellas Pharma Inc | アゾールカルボキサミド化合物又はその塩 |
| FR2953839A1 (fr) | 2009-12-14 | 2011-06-17 | Sanofi Aventis | Nouveaux derives d'(heterocycle-piperidine condensee)-(piperazinyl)-1alcanone ou d'(heterocycle-pyrrolidine condensee)-(piperazinyl)-1alcanone et leur utilisation comme inhibiteurs de p75 |
| FR2953836B1 (fr) | 2009-12-14 | 2012-03-16 | Sanofi Aventis | Nouveaux derives (heterocycle-tetrahydro-pyridine)-(piperazinyl)-1-alcanone et (heterocycle-dihydro-pyrrolidine)-(piperazinyl)-1-alcanone et leur utilisation comme inhibiteurs de p75 |
-
2011
- 2011-12-20 EP EP11306709.4A patent/EP2606894A1/en not_active Withdrawn
-
2012
- 2012-12-20 CN CN201280070033.2A patent/CN104144688B/zh not_active Expired - Fee Related
- 2012-12-20 WO PCT/EP2012/076494 patent/WO2013092918A1/en active Application Filing
- 2012-12-20 EP EP12806060.5A patent/EP2793889A1/en not_active Withdrawn
- 2012-12-20 BR BR112014014933A patent/BR112014014933A2/pt not_active IP Right Cessation
- 2012-12-20 JP JP2014548035A patent/JP6275649B2/ja not_active Expired - Fee Related
- 2012-12-20 UY UY0001034535A patent/UY34535A/es not_active Application Discontinuation
- 2012-12-20 KR KR1020147019353A patent/KR20140103151A/ko not_active Application Discontinuation
- 2012-12-20 CA CA2859582A patent/CA2859582A1/en not_active Abandoned
- 2012-12-20 AR ARP120104842A patent/AR089344A1/es unknown
- 2012-12-20 SG SG11201403390QA patent/SG11201403390QA/en unknown
- 2012-12-20 PE PE2014001001A patent/PE20141854A1/es not_active Application Discontinuation
- 2012-12-20 AU AU2012356922A patent/AU2012356922B2/en not_active Ceased
- 2012-12-20 EA EA201491226A patent/EA028616B1/ru not_active IP Right Cessation
- 2012-12-20 MX MX2014007673A patent/MX2014007673A/es unknown
-
2014
- 2014-06-17 US US14/306,882 patent/US20140296513A1/en not_active Abandoned
- 2014-06-17 IL IL233189A patent/IL233189A0/en unknown
- 2014-06-17 DO DO2014000137A patent/DOP2014000137A/es unknown
- 2014-06-17 TN TNP2014000269A patent/TN2014000269A1/en unknown
- 2014-06-18 PH PH12014501390A patent/PH12014501390A1/en unknown
- 2014-06-18 CL CL2014001619A patent/CL2014001619A1/es unknown
- 2014-06-19 CR CR20140298A patent/CR20140298A/es unknown
- 2014-06-27 CO CO14139616A patent/CO6990740A2/es unknown
- 2014-07-07 MA MA37184A patent/MA35850B1/fr unknown
- 2014-12-01 HK HK14112081.9A patent/HK1198580A1/xx unknown
-
2016
- 2016-08-10 US US15/233,227 patent/US9763940B2/en not_active Expired - Fee Related
-
2017
- 2017-09-29 JP JP2017189265A patent/JP2018030865A/ja active Pending
- 2017-10-20 AU AU2017248550A patent/AU2017248550A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY34530A (es) | Antagonistas del receptor de vanilloides de potencial transitorio 1 (trpv1) | |
| UY33966A (es) | Antagonistas del receptor transitorio potencial de vanilloides 1 (trpv1) | |
| UY34585A (es) | Compuestos b-lactámicos sustituidos con amidina, su preparación y uso | |
| CR20150296A (es) | Novedosos derivados de bencimidazol como antagonistas de ep4 | |
| GB201017345D0 (en) | Receptor antagonists | |
| UY34302A (es) | COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2- AMINA | |
| UY34778A (es) | ?COMPUESTOS DE HEXAHIDROPIRANO[3,4-d][1,3]TIAZIN-2-AMINA HETEROCÍCLICOS SUSTITUÍDOS?. | |
| UY34352A (es) | 3-pirimidin-4-il-oxazolidin-2-onas como inhibidores de la idh mutante | |
| UY34561A (es) | Compuestos dímeros agonistas de los receptores de los fgf (fgfr), su procedimiento de preparación y su aplicación en terapéutica. | |
| UY34067A (es) | Compuestos de pirrolidinil urea pirrolidinil tiourea como inhibidores de cinasa trka | |
| EA201290940A1 (ru) | Новые соединения как селективные антагонисты рецептора nk3, фармацевтическая композиция и методы их использования при нарушениях, опосредованных nk3 рецепторами | |
| UY33943A (es) | Derivados espirocíclicos de isoxazolina como agentes antiparasitarios. | |
| CL2009000873A1 (es) | Compuestos derivados de ciclohepta[b]piridina, antagonistas del receptor de cgrp; composicion farmaceutica; y uso para el tratamiento de la migrana.b | |
| UY34393A (es) | Compuestos de tetrahidroisoquinolina sustituidos como inhibidores del factor xia | |
| UY34487A (es) | Anticuerpos para receptor de factor de crecimiento epidérmico 3(her3) | |
| UY34342A (es) | ?derivados de pirrolopirimidina y purina?. | |
| UY34824A (es) | Nucleósidos de espirooxetano de uracilo | |
| EA201201357A1 (ru) | Антитела к cd40 | |
| UY33978A (es) | Piridinonas bicíclicas nuevas. | |
| EA201270619A1 (ru) | Применение бетанехола для лечения ксеростомии | |
| UY34515A (es) | Triazolopiridinas sustituidas | |
| UY34572A (es) | Compuestos heterocíclicos agonistas del receptor ip | |
| UY34467A (es) | Procedimiento para la preparación de 5-fluoro-1h-pirazolopiridinas sustituidas | |
| DOP2012000135A (es) | Compuestos de espiropiperidina como antagonistas del receptor orl-1 | |
| UY34200A (es) | 3-(fluorovinil)pirazoles y su uso |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20201020 |